Department of Surgery

Study tests drug to illuminate cancer during surgery

A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

Eunyoung Choi, PhD, James Goldenring, MD, PhD, and colleagues are studying the development of cancer in the stomach and esophagus.

Grant supports research to study gastric cancer origins

Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.

After a career of service to others, Raiford to retire

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

New high-tech biobank safeguards critical specimens

Anna Means, PhD, R. Daniel Beauchamp, MD, and colleagues are studying a group of proteins that are essential to the growth of colorectal cancer tumors.

Researchers find potential new target against colorectal cancer

John Pietsch, MD, founder of the ECMO program at Children’s Hospital, is retiring after 50 years of caring for patients.

Pediatric ECMO program founder Pietsch retires

John Pietsch, MD, the recently retired founder of the extracorporeal membrane oxygenation (ECMO) program at Monroe Carell Jr. Children’s Hospital at Vanderbilt, didn’t grow up wanting to be a doctor.

1 5 6 7 8 9 15